Company Overview and News

 
People power: consumers to help drive down electricity pricing

2018-03-29 theage.com.au
Consumers are being given the opportunity to help cut power bills and drive network companies pricing after distribution firms have been criticised for partly causing high electricity prices.

 
People power: consumers to help drive down electricity pricing

2018-03-29 smh.com.au
Consumers are being given the opportunity to help cut power bills and drive network companies pricing after distribution firms have been criticised for partly causing high electricity prices.

 
Woman forced to squat in own home as work bans halt new power connections

2018-02-15 abc.net.au
A Gippsland woman has been forced to live in a horse float for six weeks at Munro in Victoria's east due to an industrial dispute preventing new electricity connections.

 
More than 20,000 homes in city's south-east in dark after power outage

2018-02-11 smh.com.au
More than 20,000 homes in Melbourne's south-east have lost power in the third mass outage in Victoria in recent weeks.

 
Australian towns going off the grid

2018-01-02 theage.com.au
As prices rose to new highs last year and the ever-constant threat of blackouts hung over the east coast, many Australians looked for energy alternatives.

 
Australian towns going off the grid

2018-01-02 smh.com.au
As prices rose to new highs last year and the ever-constant threat of blackouts hung over the east coast, many Australians looked for energy alternatives.

1
'Unnecessary' spending by gas distributors blocked, Canberra homes to benefit

2017-10-31 smh.com.au
Canberra households look set to benefit from the latest decision by Australia's energy regulator, with "unnecessary" spending by gas distributors blocked.

 
The winners of the impending gas crunch

2017-09-26 theage.com.au
High domestic gas prices may be causing headaches for governments and consumers, but small-to-medium oil and gas producers and services companies are enjoying increasing investor interest as the market casts around for answers to the east coast gas shortage. 

 
The winners of the impending gas crunch

2017-09-26 smh.com.au
High domestic gas prices may be causing headaches for governments and consumers, but small-to-medium oil and gas producers and services companies are enjoying increasing investor interest as the market casts around for answers to the east coast gas shortage. 

 
Australia in search of a match to fire-up energy policy

2017-07-14 smh.com.au
It was once said that Brazil was a poor man sitting on a bag of gold. It could today be said of Australia that it's a cold man shivering in front of a fireplace stacked with wood, but with no matches.

 
'There's a path forward and we need to take it': Energy regulator backs clean energy target

2017-07-11 abc.net.au
The Finkel review presents a "once-in-a-generation" opportunity to fix Australia's energy system and must be backed by state and federal governments at their energy meeting on Friday, the head of market operator AusNet Services says.

 
Melbourne weather: City braces for damaging winds, heavy rain

2017-04-09 smh.com.au
A strong cold front is crossing the state, prompting a severe weather warning for damaging winds and possible flash flooding.

 
Power customers facing $84 million bill over Black Saturday stand-off

2017-04-05 smh.com.au
Victorians could be forced to fork out an extra $84 million on their power bills because of a tense standoff between the Andrews government and the owner of the state's electricity poles and wires over new bushfire prevention technology.

 
The Agency arrives in Sydney with the aim of disrupting real estate giants

2017-01-30 domain.com.au
A new player will enter Sydney’s already crowded real estate market on Wednesday with hopes not only to take market share off industry giants, but also to upset the long-established franchise model.

Related Articles

HRTX : Heron Therapeutics Analysis and Research Report

2018-05-25 - Asif

Overview Heron is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments that address some of the most important unmet patient needs. Heron Therapeutics is developing novel, patient-focused solutions that apply its innovative science and technologies to already approved pharmacological agents for patients suffering from cancer or pain. On August 9, 2016, its first commercial product, SUSTOL, was approved by the FDA. The company developed SUSTOL for the prevention of chemotherapy-induced nausea and vomiting (“CINV”). SUSTOL is indicated, in combination with other antiemetics, in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (“MEC”) or anthracycline and cyclophosphamide (“AC”) combination chemotherapy regimens. The company commenced commercial sales of SUSTOL in the U.S. in October 2016. On November 9, 2017...

ACIA: Acacia Communications Analysis and Research Report

2018-05-25 - Asif

Overview The company's mission is to deliver high-speed coherent optical interconnect products that transform communications networks, relied upon by cloud infrastructure operators and content and communication service providers, through improvements in performance and capacity and reductions in associated costs. By converting optical interconnect technology to a silicon-based technology, a process the company refer to as the siliconization of optical interconnect, the company believe Acacia Communications is leading a disruption that is analogous to the computing industry’s integration of multiple functions into a microprocessor. The company's products include a family of low-power coherent digital signal processor application-specific integrated circuits, or DSP ASICs, and silicon photonic integrated circuits, or silicon PICs, which Acacia Communications has integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per ...

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...